1-2 of 2
Susumu S. Kobayashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma

Open Access
Sho Tabata, Shigeki Umemura, Miyu Narita, Hibiki Udagawa, Takamasa Ishikawa, Masahiro Tsuboi, Koichi Goto, Genichiro Ishii, Katsuya Tsuchihara, Atsushi Ochiai, Susumu S. Kobayashi, Tomoyoshi Soga, Hideki Makinoshima
Journal: Molecular Cancer Research
Mol Cancer Res (2024) 22 (1): 82–93.
https://doi.org/10.1158/1541-7786.MCR-23-0386
Published: 02 January 2024
View articletitled, Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma
Open the PDF for Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma in another window
Includes: Supplementary data
Journal Articles

TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations

Free
Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, Rumi Fujioka, Yumi Hakozaki, Mikiko Shibuya, Naomi Abe, Toshiharu Komori, Tomonori Haruma, Miki Terasaka, Ryoto Fujita, Akihiro Hashimoto, Kaoru Funabashi, Hiroyuki Yasuda, Kazutaka Miyadera, Koichi Goto, Daniel B. Costa, Susumu S. Kobayashi
Journal: Molecular Cancer Research
Mol Cancer Res (2019) 17 (11): 2233–2243.
https://doi.org/10.1158/1541-7786.MCR-19-0419
Published: 01 November 2019
View articletitled, TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations
Open the PDF for TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations in another window
Includes: Supplementary data